PROFESSIONAL EDITION

The largest community of pharma leaders

Maze Therapeutics Appoints Jason Coloma as Chief Executive Officer and Expands Leadership Team

SAN FRANCISCO–(BUSINESS WIRE)–Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jason Coloma, Ph.D., Maze’s current chief operating officer, has been appointed as chief executive officer. He succeeds interim CEO, Charles Homcy, M.D., who will assume the role of chairman of the company’s board of directors. In addition, Maze announced the appointment of Matt Krause, a nearly 25-year human resources leader, as senior vice president of http://www.businesswire.com/news/home/20190618005128/en/Maze-Therapeutics-Appoints-Jason-Coloma-Chief-Executive/?feedref=JjAwJuNHiystnCoBq_hl-c_SXB-bY2T43rxUBWxEIvSqcp-o_pnudlUwsb5apQ1S4gUE65BTfjH3-pSuqdv0gW3cb3F4oTIgUqCPafFkgu61_izUl0FZkbDFZ7ZhSEmC

Recent Articles